UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 23.

Güngör, T; Teira, P; Slatter, M; Stussi, G; Stepensky, P; Moshous, D; Vermont, C; Ahmad, I; Shaw, P J; da Cunha, J M; Schlegel, P G; Hough, R; Fasth, A; Kentouche, K; Gruhn, B; Fernandes, J F; Lachance, S; Bredius, R; Resnick, I B; Belohradsky, B H; Gennery, A; Fischer, A; Gaspar, H B; Schanz, U; Seger, R; Rentsch, K; Veys, P; Haddad, E; Albert, M H; Hassan, M (2014). Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet, 383(9915):436-448.

Marek, A; Stern, M; Chalandon, Y; Ansari, M; Ozsahin, H; Güngör, T; Gerber, B; Kühne, T; Passweg, J R; Gratwohl, A; Tichelli, A; Seger, R; Schanz, U; Halter, J; Stussi, G (2014). The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplantation, 49(1):55-61.

Brendel, C; Hänseler, Walther; Wohlgensinger, Vital; Bianchi, Matteo; Tokmak, Serap; Reichenbach, J; Seger, R; Siler, Ulrich (2013). Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy. Human Gene Therapy. Methods, 24(3):151-159.

Liu, L; Okada, S; Kong, X F; Kreins, A Y; Cypowyj, S; Abhyankar, A; Toubiana, J; Itan, Y; Audry, M; Nitschke, P; Masson, C; Toth, B; Flatot, J; Migaud, M; Chrabieh, M; Kochetkov, T; Bolze, A; Borghesi, A; Toulon, A; Hiller, J; Eyerich, S; Eyerich, K; Gulácsy, V; Chernyshova, L; Chernyshov, V; Bondarenko, A; Grimaldo, R M C; Blancas-Galicia, L; Beas, I M M; Roesler, J; Magdorf, K; Engelhard, D; Thumerelle, C; Burgel, P R; Hoernes, M; Drexel, B; Seger, R; Kusuma, T; Jansson, A F; Sawalle-Belohradsky, J; Belohradsky, B; Jouanguy, E; Bustamante, J; Bué, M; Karin, N; Wildbaum, G; Bodemer, C; Lortholary, O; Fischer, A; Blanche, S; Al-Muhsen, S; Reichenbach, J; Kobayashi, M; Rosales, F E; Lozano, C T; Kilic, S S; Oleastro, M; Etzioni, A; Traidl-Hoffmann, C; Renner, E D; Abel, L; Picard, C; Maródi, L; Boisson-Dupuis, S; Puel, A; Casanova, J L (2011). Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine, 208(8):1635-1648.

Grez, M; Reichenbach, J; Schwäble, J; Seger, R; Dinauer, M C; Thrasher, A J (2011). Gene therapy of chronic granulomatous disease: the engraftment dilemma. Molecular Therapy, 19(1):28-35.

Hoernes, M; Seger, R; Reichenbach, J (2011). Modern management of primary B-cell immunodeficiencies. Pediatric Allergy and Immunology, 22(8):758-769.

Al-Herz, W; Bousfiha, A; Casanova, J L; Chapel, H; Conley, M E; Cunningham-Rundles, C; Etzioni, A; Fischer, A; Franco, J L; Geha, R; Hammarstrom, L; Nonoyama, S; Notarangelo, L D; Ochs, H D; Puck, J; Roifman, C M; Seger, R; Tang, M (2011). Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Frontiers in Immunology:2:54.

Nakagawa, N; Imai, K; Kanegane, H; Sato, H; Yamada, M; Kondoh, K; Okada, S; Kobayashi, M; Agematsu, K; Takada, H; Mitsuiki, N; Oshima, K; Ohara, O; Suri, D; Rawat, A; Singh, S; Pan-Hammarström, Q; Hammarström, L; Reichenbach, J; Seger, R; Ariga, T; Hara, T; Miyawaki, T; Nonoyama, S (2011). Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. Journal of Allergy and Clinical Immunology, 128(1):223-225.e2.

Schimke, L F; Sawalle-Belohradsky, J; Roesler, J; Wollenberg, A; Rack, A; Borte, M; Rieber, N; Cremer, R; Maass, E; Dopfer, R; Reichenbach, J; Wahn, V; Hoenig, M; Jansson, A F; Roesen-Wolff, A; Schaub, B; Seger, R; Hill, H R; Ochs, H D; Torgerson, T R; Belohradsky, B H; Renner, E D (2010). Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. Journal of Allergy and Clinical Immunology, 126(3):611-617.e1.

Stein, S; Ott, M G; Schultze-Strasser, S; Jauch, A; Burwinkel, B; Kinner, A; Schmidt, M; Krämer, A; Schwäble, J; Glimm, H; Koehl, U; Preiss, C; Ball, C; Martin, H; Göhring, G; Schwarzwaelder, K; Hofmann, W K; Karakaya, K; Tchatchou, S; Yang, R; Reinecke, P; Kühlcke, K; Schlegelberger, B; Thrasher, A J; Hoelzer, D; Seger, R; von Kalle, C; Grez, M (2010). Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nature Medicine, 16(2):198-204.

Passweg, J; Baldomero, H; Stern, M; Bargetzi, M; Ghielmini, M; Leibundgut, K; Duchosal, M; Hess, U; Seger, R; Buhrfeind, E; Schanz, U; Gratwohl, A (2010). Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect. Swiss Medical Weekly, 140(23-24):326-334.

Frei, R; Steinle, J; Birchler, T; Loeliger, S; Roduit, C; Steinhoff, D; Seibl, R; Büchner, K; Seger, R; Reith, W; Lauener, R P (2010). MHC class II molecules enhance Toll-like receptor mediated innate immune responses. PLoS ONE, 5(1):e8808.

Wohlgensinger, V; Seger, R; Ryan, M D; Reichenbach, J; Siler, U (2010). Signed outside: a surface marker system for transgenic cytoplasmic proteins. Gene Therapy, 17(10):1193-1199.

Freudenberg, Folke; Wintergerst, Uwe; et al; Seger, R (2010). Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. Journal of Allergy and Clinical Immunology, 125(4):943-946.e1.

Gennery, A R; Slatter, M A; Grandin, L; Taupin, P; Cant, A J; Veys, P; Amrolia, P J; Gaspar, H B; Davies, E G; Friedrich, W; Hoenig, M; Notarangelo, L D; Mazzolari, E; Porta, F; Bredius, R G M; Lankester, A C; Wulffraat, N M; Seger, R; Güngör, T; Fasth, A; Sedlacek, P; Neven, B; Blanche, S; Fischer, A; Cavazzana-Calvo, M; Landais, P (2010). Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? Journal of Allergy and Clinical Immunology, 126(3):602-610.e11.

Güngör, T; Scherer, F; Molinari, L; Schmugge, M; Bourquin, J P; Niggli, F; Seger, R (2009). Überlebensrate und Mortalität nach allogener und autologer hämatopoietischer Stammzelltransplantation (HSZT) an den Universitäts-Kinderkliniken Zürich: eine vergleichende Analyse von 1991 bis 2006. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 29(1):41-44.

Qasim, W; Cavazzana-Calvo, M; Davies, E G; Davis, J; Duval, M; Eames, G; Farinha, N; Filopovich, A; Fischer, A; Friedrich, W; Gennery, A; Heilmann, C; Landais, P; Horwitz, M; Porta, F; Sedlacek, P; Seger, R; Slatter, M; Slatten, M; Teague, L; Eapen, M; Veys, P (2009). Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics, 123(3):836-840.

Eberle, P; Berger, C; Junge, S; Dougoud, S; Valsangiacomo Büchel, Emanuela R; Riegel, M; Schinzel, A; Seger, R; Güngör, T (2009). Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome. Clinical and Experimental Immunology, 155(2):189-198.

Notarangelo, L D; Fischer, A; Geha, R S; Casanova, J-L; Chapel, H; Conley, M E; Cunningham-Rundles, C; Etzioni, A; Hammartröm, L; Nonoyama, S; Ochs, H D; Puck, J; Roifman, C; Seger, R; Wedgwood, J (2009). Primary immunodeficiencies: 2009 update. Journal of Allergy and Clinical Immunology, 124(6):1161-1178.

Marti, P; Molinari, L; Bolt, I B; Seger, R; Saurenmann, R K (2008). Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. European Journal of Pediatrics, 167(4):425-430.

Bolt, I B; Cannizzaro, E; Seger, R; Saurenmann, R K (2008). Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. The Journal of Rheumatology, 35(4):703-706.

Junge, S; Kloeckener-Gruissem, B; Zufferey, R; Keisker, A; Salgo, B; Fauchere, J C; Scherer, F; Shalaby, T; Grotzer, M; Siler, U; Seger, R; Güngör, T (2007). Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. European Journal of Immunology, 37(11):3270-3280.

Birchler, T; Seibl, R; Büchner, K; Loeliger, S; Seger, R; Hossle, J P; Aguzzi, A; Lauener, R P (2001). Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. European Journal of Immunology, 31(11):3131-3137.

This list was generated on Tue Jul 25 14:00:49 2017 CEST.